Development and in vivo evaluation of gastroretentive delivery systems for cefuroxime axetil

被引:31
|
作者
Rao, Govikari Koteshwar [1 ]
Mandapalli, Praveen Kumar
Manthri, Rajendraprasad [2 ]
Reddy, Veerareddy Prabhakar [2 ]
机构
[1] Pragati Pharm Coll, Dept Pharm, Warangal, Andhra Pradesh, India
[2] Chaitanya Coll Pharm, Warangal, Andhra Pradesh, India
关键词
Gastroretentive tablets; Floating delivery system; Cefuroxime axetil; Radiographic studies; GASTRIC RESIDENCE; DRUG-DELIVERY; TABLETS; RELEASE; UNIT;
D O I
10.1016/j.jsps.2012.01.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this investigation was to design and develop gastroretentive dosage form for cefuroxime axetil using floating tablet approach with various grades of hydroxypropyl methyl cellulose. Cefuroxime axetil is known to have low bioavailability, short half-life and is absorbed -largely from upper GIT. Sodium bicarbonate was used in the dosage form as a source of carbon-di-oxide to maintain buoyancy. In vitro dissolution study results indicated non-Fickian diffusion controlled drug release mechanism and was best fitted into Korsmeyer-Peppas equation. In vivo radiographic studies conducted in five healthy human volunteers for optimized formulation indicated over 6 h retention of tablet in the stomach region. Reproducible physical parameters indicated that the current formulation could be easily scaled-up. (C) 2012 King Saud University. Production and hosting by Elsevier B. V. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [1] Development of gastroretentive drug delivery system for cefuroxime axetil: In vitro and in vivo evaluation in human volunteers
    Bomma, Ramesh
    Veerabrahma, Kishan
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (05) : 1230 - 1237
  • [2] Formulation Development and Evaluation of a Gastroretentive in situ oral gel of Cefuroxime Axetil
    Shastri, Divyesh Harshadkumar
    Dodiya, Hitesh Dhirubhai
    Shelat, Pragna
    Bhanupriy, Alkesh Kishanlal
    JOURNAL OF YOUNG PHARMACISTS, 2016, 8 (04) : 324 - 329
  • [3] Formulation Development, Characterization, and Evaluation of Controlled Nasal Drug Delivery Systems for Cefuroxime Axetil
    Rajarajan, S.
    Rao, B. Prakash
    Selvamuthukumar, S.
    ASIAN JOURNAL OF PHARMACEUTICS, 2020, 14 (04) : 620 - 628
  • [4] Cefuroxime Axetil Loaded Gastroretentive Floating TabletsBased on Hydrophilic Polymers: Preparation and In Vitro Evaluation
    Mohapatra, Snehamayee
    KumarKar, Rajat
    Mohapatra, Debendra Kumar
    Sahoo, Sunit Kumar
    Barik, Bhakti Bhusan
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2012, 55 (02) : 269 - 275
  • [5] Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation
    Patel, VF
    Patel, NM
    AAPS PHARMSCITECH, 2006, 7 (01):
  • [6] Formulation development, optimization and characterization of mucoadhesive minitablets of cefuroxime axetil: in vitro, ex vivo and in vivo pharmacokinetic evaluation
    Jayanti Panda
    Muddana Eswara Bhanoji Rao
    Suryakanta Swain
    Chinam Niranjan Patra
    Bikash Ranjan Jena
    Beni-Suef University Journal of Basic and Applied Sciences, 11
  • [7] Formulation development, optimization and characterization of mucoadhesive minitablets of cefuroxime axetil: in vitro, ex vivo and in vivo pharmacokinetic evaluation
    Panda, Jayanti
    Rao, Muddana Eswara Bhanoji
    Swain, Suryakanta
    Patra, Chinam Niranjan
    Jena, Bikash Ranjan
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2022, 11 (01)
  • [8] Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation
    Viral F. Patel
    Natavarlal M. Patel
    AAPS PharmSciTech, 7 (1)
  • [9] Chitosan-based intragastric delivery of cefuroxime axetil: Development and in-vitro evaluation of mucoadhesive approach
    Nagar, Mitesh
    Yadav, Adhikrao V.
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2012, 40 (06): : 406 - 418
  • [10] In vitro Dissolution and in vivo Bioequivalence Evaluation of Two Brands of Cefuroxime Axetil Tablets
    Choi, Yoonho
    Jin, Su-Eon
    Lee, Mi-Kyung
    Kim, Chong-Kook
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2009, 59 (01): : 42 - 48